Furthermore, reduced FABP1 expression has been documented in MSI-high (microsatellite instability-high) colorectal cancers, potentially attributable to the IFNγ-mediated suppression of PPARG within their highly immunoreactive microenvironment [66]. This evidence concerns the gene FABP1 and colorectal cancer.